ArticleEpilepsia open2026

Preliminary evidence of long-term safety and effectiveness of anti-CGRP drugs for migraine prevention in people with comorbid epilepsy: A 52-week follow-up retrospective study.

Marina Romozzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.